English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Dr. Saul Hertz spontaneously posed the question "Could iodine be made radioactive artificially?" to the MIT President Karl Compton, on November 12, 1936. MGH's Dr. Hertz and his MIT collaborator, Dr. Arthur Roberts, were the first and the foremost to develop the experimental data for the medical uses of radioiodine (RAI) and apply it in the clinical setting. Dr. Hertz expanded the successful use of RAI of treating hyperthyr‐ oidism, Graves‘ disease, to the treatment of thyroid cancer in 1946. Dr. Saul Hertz established the Radioactive Isotope Research Institute to diagnose and treat thyroid cancer, which he believed held the key to the larger problem of cancer in general. RAI is the first and gold standard of targeted cancer therapies.

Dr. Saul Hertz (1905–1950) Discovers the Medical Uses of Radioactive Iodine: The First Targeted Cancer Therapy